FDA Classifies AI-Powered Digital Cervical Cytology Imaging System as Class II
FDA · US
This de novo order establishes a formal Class II (special controls) pathway for AI-driven cervical cytology slide imaging — creating a regulatory template that manufacturers of comparable AI-assisted pathology tools can reference for 510(k) submissions. Teams developing AI/ML diagnostic software should study the special controls language carefully, as it will shape predicate-based submissions across hematology and pathology device categories.
Read the source →